NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) | RFA CA 19 029

Opportunity Information: Apply for RFA CA 19 029

The NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed), listed as RFA-CA-19-029, is a National Cancer Institute (NCI) grant mechanism under the U.S. Department of Health and Human Services (HHS) and the National Institutes of Health (NIH). Its central goal is to strengthen the pipeline of independent cancer researchers by supporting a select group of outstanding early-stage postdoctoral fellows as they move from a mentored postdoctoral environment into independent, tenure-track (or equivalent) faculty roles. In practical terms, the program is meant to shorten the time it takes for highly prepared postdocs to become independent investigators while ensuring they have resources and structured support during that critical transition.

The award is specifically aimed at postdoctoral researchers who hold a research doctoral degree and/or a clinical doctoral degree and who are already positioned to become independent without needing a long additional period of mentored training beyond what they have completed in their doctoral and postdoctoral work. The intent is not to provide another extended training experience, but to create a clear, supported bridge from a mentored postdoctoral appointment to a first independent academic or equivalent research position. NCI is using this program to maintain a strong cohort of new, talented investigators who can compete successfully for future funding and establish productive cancer-focused research programs.

Structurally, the K99/R00 format is designed as a two-phase pathway. The first phase (K99) supports the applicant while they are still in a mentored postdoctoral position, helping them complete key research and career development steps that position them for independence. The second phase (R00) provides research support after the awardee secures an independent, tenure-track or equivalent position, with the purpose of helping them launch their independent lab or research program and generate the early outputs that make an investigator competitive long-term. Although the provided synopsis does not list specific budget caps (the award ceiling is shown as 0 in the source data), the program description makes clear that the R00 portion is intended to provide independent NCI research support during the transition into a faculty role.

A notable emphasis in this opportunity is NCI's encouragement of applications in data science and cancer control science. This signals that NCI is especially interested in supporting early investigators whose work aligns with modern cancer research needs such as advanced analytics, computational approaches, large-scale data integration, implementation science, prevention, survivorship, healthcare delivery, behavioral research, and population-level strategies to reduce cancer burden. While applications are not limited to these areas, the encouragement indicates these fields are priorities for building the next generation of independent NCI-funded researchers.

The opportunity is classified as a discretionary grant within the education and health activity category (CFDA 93.398). Eligibility, at the organizational level, is broad and includes many types of U.S.-based entities such as public and private institutions of higher education, nonprofit organizations (including 501(c)(3) and non-501(c)(3) entities), for-profit organizations (including small businesses), and various government entities (state, county, city/township, special districts), as well as eligible Native American tribal governments and tribal organizations and public housing authorities/Indian housing authorities. This broad eligibility reflects NIH's typical approach of allowing many organization types to serve as the applicant institution, though the award itself is fundamentally designed to support an individual postdoctoral researcher’s career progression within an eligible sponsoring organization and then within a subsequent independent institution.

The title also specifies "Independent Clinical Trial Not Allowed," which means the mechanism does not permit the awardee to lead an independent clinical trial as part of the funded project. In other words, the supported research should not be structured around the applicant serving as the responsible party for conducting an independent clinical trial. This restriction is important for applicants working near clinical research boundaries, because it shapes the kinds of aims, methods, and study designs that are appropriate under this funding announcement.

From the source data, the funding opportunity was created on December 20, 2018, and the original closing date was February 26, 2019, with an expected number of 16 awards. Overall, the K99/R00 described here is a career-accelerating mechanism that identifies highly promising postdoctoral researchers in cancer-relevant fields and provides a defined, staged path to independence: mentored support to finalize the transition plan and research direction, followed by independent support to establish a competitive, self-sustaining research career under NCI’s mission.

• The Department of Health and Human Services, National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398.
• This funding opportunity was created on Dec 20, 2018.
• Applicants must submit their applications by Feb 26, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 16 candidate(s).
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for RFA CA 19 029

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: